DR. VIRAJ RAMESH SUVARNA

Patient-driven Medical Director offering 26 years history managing leading Pharmaceuticals functions to optimize operations and foster superior organization-wide service delivery. Expert in medical affairs for effective patient care and faster new drug launches. Focused on continuous quality improvement and leadership development.

• Date of Birth: 05/27/67
• Gender: Male
• Nationality: Indian
• Marital Status: Married

Significant achievements:

BI India has grown significantly from the time I joined in July 2010 to where it is now (from 10 crores to >1000 crores when I left). The medical team has also grown and is a significant contributor to the business in all the five functions, as attested to by the managing, sales and marketing directors, and widely recognized by industry as well. Be it the leveraging of global CTs for the local business, expediting regulatory approvals for both CTAs and NDAs despite the difficult environment, maintaining quality and compliance, promoting PV as a specialty, or being the medical driver of the business, including local CD projects, and external expert engagements, the One Medical team is at the forefront, being one with each other and one with the business. I was awarded for exemplifying all the four BI Values (Passion, Empathy, Respect for People, Trust). After I left, the Head of Medical Affairs was made the Medical Director.

As Executive Committee member of the Indian Society for Clinical Research (ISCR) and Chair of the Investigator Council, I helped bring about some change in the regulatory environment for CTs for the better (changes related to compensation, not more than 3 CTs rescinded, 50% sites from government hospitals no longer applicable). Activities included many investigator outreach meetings, training workshops, media briefings, getting investigators to interact with the MoH/DCGI/DGHS, developing a film on CR for the lay public and hosting many meetings on May 20, International CT Day. Was appointed to represent Asia-MENA region on the OPTIMA project of optimizing the Medical Affairs function.

Was a member of the Subject Board at the St. Xavier’s College, Mumbai tasked with curriculum development for those aspiring to join the medical department of the pharmaceutical industry.

Am a certified trainer in Leading Edge II having undergone a train the trainer program and then was faculty for situational leadership workshops for Pfizer senior managers.

Passed with first class honors (overall grade 73%) a 2 years online Master of Science (MSc) course in Pharmaceutical Medicine conducted by Hibernia University, Dublin, Ireland in collaboration with Harvard University, Boston and accreditated by Higher Education Technical Awards Council (HETAC), Ireland and International Federation of Associations of Pharmaceutical Physicians (IFAPP)

Received the Pfizer WE Upjohn Award for Innovation in 2006 for conceptualizing the Microbiologist Interface with Clinicians (MIC) initiative that was recognized as a value-added service of our antibacterial portfolio. Conceptualized the “Why Risk the Benefit‟ program for Fragmin which also won the Upjohn award.

Within 8 months of joining Pfizer, I was assigned responsibility of launching Magnex (sulbactam-cefoperazone), a product that had tremendous initial success, was ranked number 4 among best launches for the year 2000-1, and won the Golden Peacock award given by the Institute Of Directors (IOD) to the most innovative product across various industries. Was product physician for Minipress XL (prazosin GITS) which won the OPPI Brand Excellence award. Contributed towards the PRIME MD TODAY initiative of translating, back-translating and validating a questionnaire, and working with KOLs in evolving a simplified treatment algorithm, thus enabling primary care practitioners diagnose and treat major depressive disorder in conjunction with psychiatrists, which also bagged the Golden Peacock award.

Member of the Core Committee of the first Indian guidelines on Minimal Access Surgery, released by President of India at Rashtrapati Bhavan on July 15th, 2002. Member of the Core Committee of the first Indian guidelines on Febrile Neutropenia, released by Mr. Sunil Dutt MP in Delhi on December 13th, 2003. Author of chapter on Infection Control during Laparoscopy in the first Indian Minimal Access Surgery Guidelines and Recommendations. Author of chapter on Clinical Pharmacology in the first Indian Guidelines on Febrile Neutropenia. Member of the Core Committee of the updated Indian guidelines on Hypertension, released by the Honorable Minister of State, Goa at the API conference on Feb 15, 2007.

Section Editor of Perspectives in Clinical Research, the official journal of the Indian Society for Clinical Research (ISCR), Referee/Peer Reviewer for Indian Journal of Pharmacology, Peer reviewer for the Indian Journal of Public Health since November 2001, Faculty for Diploma in CR course run by Academy of Clinical Excellence, Mumbai College of Pharmacy, Kalina, and for TMH, Mumbai.

M.D. Thesis:

A study of the anti-convulsant activity of Nimodipine alone and in combination with other anti-epileptic agents in comparison with that of other calcium channel blockers in experimental animals.

Paper Presentation:

Annual Meeting of Research Society - G.M.C. & the Sir J J Group of Hospitals on 17 Sept. 1998 “Evaluation of the anti-convulsant potential of Nimodipine”.

Poster Presentation:

Exploring the availability and characteristics of healthcare cost data across selected Asian countries. PHP12. p 68 International Society of Pharmacoeconomics and Outcomes Research (ISPOR), 2nd Asia-Pacific Conference, Shanghai March 6th-7th 2006.

Publications:

1. Drugs and Hepatotoxicity. BioMed 1999; 6(7): 10-14.

2. Fenugreek/Methi (Trigonella foenum graecum). Asian Journal of Diabetology 1999; 1(3): 53-57.

3. Erythropoeitin. Physician’s Digest 1997; 5(6): 24-34.

4. An open, non-comparative study of the efficacy and safety of sulbactam-cefoperazone (1:1) in the empirical treatment of moderate to severe systemic bacterial infections in hospitalized patients. Hospital Today 2002; 7(6): 311-320.

5. SARS and Immunity. Express Pharma Pulse May 8, 2003.

6. Prevalence of β-lactamase producing strains among clinical isolates obtained from hospital in-patients across India and comparison of antibacterial susceptibility using disc-diffusion method. Investigators: Expert Group on Antibiotic Susceptibility Tests (EGAST) 2000. Hospital Today Jan-Mar 2004; 9(1): 70-80.

7. Prazosin GITS in patients with benign prostatic hyperplasia: a 4 week, prospective, open, multi-center study. Indian J Urol June 2004; Suppl 6, Number 1, p 20-28. 8. A single dose, randomized, crossover study to compare the pharmacokinetics of 2.5 mg sustained release tablets of Prazopress XL (prazosin OPS) and Minipress XL ([prazosin GITS) in 24 healthy adult male subjects. Indian J Urol June 2004; Suppl 6, Number 1, p 29-38.

9. Hyperhomocysteinemia – an emerging risk factor for atherosclerotic vascular disease (AVD) in Indians? Indian Journal of Endocrinology and Metabolism 2005; 7(1): 15-22. 10. Calf vein thrombosis – From a patient‟s perspective. Atherothrombosis Update 2004; 1(3): 8-10.

11. Post-marketing Surveillance. The Pfizer Medical Journal Nov-Dec 2004, p 2-3. 12. Patenting Incremental Innovations – Advantage India. Express Pharma Pulse March 24, 2005, p 10, 16.

13. Outcomes Research – a holistic approach to patient care. Pharma Times July 2006; 38(7): 15-17.

14. New patent regime spurs need to innovate. Chronicle Pharmabiz September 28, 2006, p 41-2.

15. Disease Management – a new paradigm. Pharma Times 2006; 38(10): 30-35. 16. Disease Management – old wine or much more? Express Pharma Pulse, Nov 16-30, 2006, p 91-92.

17. Co-authored Chapter 32 titled “Hyperhomocysteinemia and hypertension: is there an association?” In: Hypertension An International Monograph 2007 edited by M. Paul Anand and M Y Nadkar, IJCP Group of Publications, p 331-339.

18. Informed Consent – the mainstay of GCP. ISCR Bulletin May 2007, Vol. 1, Issue 5, page 2.

19. Cost-Effectiveness Study Comparing Cefoperazone-Sulbactam to a Three-Drug Combination for Treating Intra-abdominal Infections in an Indian Health-Care Setting. Value in Health 2008; 11(Supplement 1): S33-S38.

20. Translation and validation of BPHQ (Brief Patient Health Questionnaire) against DSM IV as a tool to diagnose major depressive disorder in Indian patients. J Postgrad Med 2007; 53(2): 102-107.

21. Quality assurance practices in medical information departments of pharmaceutical companies: an Indian scenario. International Pharmaceutical Industry www.ipimedia.com, p 16, 18-20.

22. Phase IV studies. Perspectives in Clinical Research, April 2010.

23. The guinea pig syndrome – perception or reality? Express Pharma April 1-15, p 26. 24. Editorial in Perspectives in Clinical Research, official journal of the Indian Society for Clinical Research. April 2010 issue. CONSORT: Revised anew?

25. Opinion piece on Commitment to Safety by the Industry in Perspectives in Clinical Research, official journal of the Indian Society of Clinical Research. October 2010 issue.

26. Health technology assessment and its role in the future development of the Indian healthcare sector. Hass B, Pooley J, Feuring M, Suvarna V, Harrington AE. Perspectives in Clinical Research 2012; 3(2): 66-72.

27. Investigator Initiated Trials. Editorial. Perspectives in Clinical Research. Oct-Dec 2012; p 1-2.

28. CONFERENCE SYMPOSIUM: Pharmacovigilance Symposium ISCR Annual Conference Jan 5, 2013: Safety aspects of hard endpoints. Viraj Suvarna, Indu Nambiar, Shoibal Mukherjee, Mohandas K Mallath. Perspectives in Clinical Research. 2013; 4(2): 148-152.

29. Comparisons are odious. Editorial. Perspectives in Clinical Research, Oct-Dec 2014. 30. Practical challenges in conducting respiratory studies. Perspectives in Clinical Research. Jan-Mar 2015; 6(1): 15-19.

31. Involvement of general public in biomedical research. CS Pramesh, R Venkataramanan, Viraj Suvarna, Nishu Singh Goel, S Lakshman, Viji Venkatesh, Vandana Gupta, Rajendra Badwe. Perspectives in Clinical Research. 2016; 7(4): 152-155.

32. Long-term efficacy and safety of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes mellitus in Indian sub-group: Results from a 76-week extension trial of a Phase III double-blind randomized study. Sunil Gupta, Shehla Shaikh, Pooja Joshi, Shraddha Bhure, Viraj Suvarna. Indian Journal of Endocrinology and Metabolism 2017; 21 (2): 286-292.

33. Usefulness of ambulatory blood pressure measurement for hypertension management in India: the India ABPM study. Kaul U et al. Journal of Human Hypertension 2019, https://doi.org/10.1038/s41371-0190243-6.

34. Blood Pressure related to Age: The India ABPM study. Kaul U et al. J Clin Hypertens. 2019; 00; 1-11. DOI: 10.1111/jch.13744.

35. Validation of BP monitoring devices. Suvarna V et al. Clin J Hypertension 2019; 3(4): 15- 19.

36. Self-blood pressure measurement as compared to office blood pressure measurement in a large Indian population: the India Heart Study. Kaul U et al. Journal of Hypertension 2020; 38(1); 1-9.

37. Blood pressure and heart rate related to sex in untreated subjects, The India ABPM study. Kaul U et al. Journal of Clinical Hypertension 2020. DOI: 10.1111/jch.13894 38. Managing COVID-19 in India: STRICT 3C. Joshi SR, Suvarna V. JIMA June 2020; 118(6): 13-16.

39. Vitamin D and its role in Corona Virus Disease 2019 (COVID-19). Suvarna V, Mohan V. Journal of Diabetology June 24, 2020; 11: 71-80.

40. Gender vulnerability in COVID-19: do we know why? Fertility & Sterility September 15, 2020.

41. Suvarna VR. Sodium glucose co-transporter-2 inhibitors: A cardiovascular outcome trial analysis. Perspectives in Clinical Research Jan 2021; 12: 4-8.

42. Sawhney JPS, Suvarna VR, Chopra HK. Power and promise of Home BP monitoring. In: Hypertension New Frontiers 2021, a Textbook of Cardiology, edited by Dr. HK Chopra et al, Chapter 43, pages 262-266.

43.Polavarapu NK, Gaurav K, Suvarna VR, Matthew J, Sethi BK, Yadav UM. Dapagliflozin in clinical practice: benefits beyond glycemic control. An Expert Review from India. International Journal of Diabetes. 2021; 2(1): 76-90.

44.Kaul U, Suvarna V, Verberk W. Importance of self/home blood pressure measurement and its relevance in the COVID era. JAPI July 2021; 69(7): 92-93. Correspondence.

Six more publications.

External presentations:

Presented on validation of BP measuring devices and monitoring of BP at Calicut Diabetes Forum, September 13, 2019

Validation of BP measurement devices, HSICON, September 21, 2019, Mumbai ∙ Understanding Patient-Centricity in Clinical Trials: The Role of Patient-Reported Outcomes, Indian Patient Access Summit, August 30, 2019, Mumbai

Keynote address at the Indian Medical Advisors Summit, Mumbai, Feb 22, 2014 ∙ Co-chaired a session on Academic Clinical Research at the 7th annual ISCR conference, Bengaluru, Jan 11, 2014

Presented at AFMC, Pune on May 21, 2013 on Data Safety Management Board ∙ Presented at National Institute for Research in Reproductive Health (ICMR), Mumbai, Workshop on GCP and Manuscript Writing, on Safety aspects of CTs, 16th-18th April 2013 ∙ Presented at Pharmatech KEM Hospital, Mumbai, 1st to 10th April 2013, on Development of Biologics

Moderated a Pharmacovigilance symposium on outcome trials and presented on Investigator Initiated Research at the 6th annual ISCR conference at ITC Maratha in Mumbai on Jan 4-5, 2013

Presentation on “Biosimilars an even greater need for pharmacovigilance” at Pharmacovigilance Summit India, Intercontinental Hotel, Mumbai, June 27-29, 2011 ∙ Presentation on Protocol and Manuscript writing at a workshop on Clinical Research methodology organized by MUHS at Haffkine Institute on March 27, 2011

Presentation on Phases 2 to 4 of Clinical Trials at Pharmatech 2011 in KEM hospital on March 26, 2011 (19 credit hours)

Presentation on biologics and biosimilars in pharmacoinvasive therapy at the API Aurangabad chapter on 6th Feb, 2011

Presentation on Informed Consent at the Academy of Clinical Excellence, Bombay College of Pharmacy, Kalina, 23rd Jan, 2011

Presentation on comparative effectiveness research and panel discussion on CT interfaces at the Indian Association of Statistics in Clinical Trials, Mumbai, 22nd Jan, 2011

Panel discussion on Pharmacovigilance at Apollo Hospital, Delhi, 18th October, 2010 ∙ Presentation on pharmacogenomics at TNMC and BYL Nair hospital in September 2010 ∙ Presentations on QC/QA and Legal aspects of CTs at ACE, Bombay College of Pharmacy, Kalina on 29th August 2010

Regulatory landscape in clinical drug development – global vis a vis Indian perspective at 42nd annual IPS meeting, Kolkata on December 11, 2009

Finding practical solutions to safe and high quality clinical trials in India – bioLogics international conference 2009 at Grand Hyatt, Mumbai on December 3, 2009 ∙ Non-interventional studies – Emerging Superpowers in Clinical Research a Next Level Pharma conference in Amsterdam 28th-29th May 2009

Improving investigator and patient relationships and motivating investigators by innovative training techniques – 3rd Annual Clinical Development and Outsourcing in Central and Eastern Europe – a Next Level Pharma conference in Bratislava on September 22nd-23rd 2008

Outcomes Research a holistic approach – Workshop at Pradanya - National Conference on Globalization & Healthcare, Institute of Health management Research, Jaipur, in collaboration with Academy of Hospital Administration, India on December 8, 2007

Multiple risk factors in management of hypertension – A ward Association; presentation and panel discussion, November 18, 2007

Updated Indian Hypertension Guidelines – HOLD (Hypertension, Obesity, Lipids, Dyslipidemia) meeting organized by HSI (Hypertension Society of India), November 2, 2007

Inhaled insulin – MV Diabetes Center, Chennai, September 3, 2007. ∙ Opportunities and challenges of setting up global clinical trials in emerging countries. Optimizing Clinical Trials 2007. Amsterdam. May 29, 2007.

Recent HT guidelines – its relevance to Indian scenario. Mumbai chapter of API, 6th May, 2007

Overview of GCP & Clinical Research, CT monitoring, Safety reporting, and Regulatory aspects of clinical research in India at PGI, Chandigarh on 18th March, 2007 ∙ Comparison of beta-lactam/beta-lactamase inhibitor combinations, to the Infectious Diseases group at P. D. Hinduja hospital, Mumbai on 16th March, 2007.

Overview of GCP & Clinical Research, Ethics and Clinical Research, Informed Consent, and Indian regulations at GCP workshop organized by ACE, Hyderabad on 25th February, 2007

Drug discovery, development and commercialization, at the 62nd annual conference of API at Kala Academy, Goa on 18th February, 2007

Drug discovery, development, patents, and overview of clinical research, at Bombay College of Pharmacy, Kalina on 17th February, 2007

Drug discovery – pharmaceutics and biotherapeutics, at an international conference on advances in pharmaceutical microbiology at St. Xavier’s College conducted as part of 75th year celebrations of the Department of Microbiology, on January 7, 2007

Report Writing and Publishing - IDMA-GOI/CDSCO GCP Workshop Practicing what is Preached, 25th November, 2006

Intellectual Property Protection and Healthcare – Directorate of Health Services, Delhi, 19th November, 2006

Writing of SOPs; Forms and Logs – ACE Diploma in GCP Course, Bombay College of Pharmacy, 18th November, 2006

History of Clinical Research Regulations and Informed Consent – ACE - GCP workshop, Sahyadri Hospital, Pune, 23rd September 2006.

“Cardio-Renal Cascade in Hypertensives” at the Mumbai Nephrology Society meeting at Piramal Hospital, Parel, on 30th August, 2006.

CRF Designing, Documentation, and Data Analysis – Training Course on Clinical Research Methodology, Dept., Clinical Pharmacology, Nair Hospital, 19th April 2006.

“New Drug Discovery and Development” – NIMHANS 20th Jan 2006

“Outcomes Research – a holistic approach to healthcare” – Meeting organized by Tata Institute of Social Sciences & American College of Healthcare Executives, 8th Jan 2006

“An Introduction to GCP” – CDSCO/WHO workshop on GCP at VP Chest Institute, New Delhi on 25th Nov 2005

“Management of Systemic Fungal Infections” – International Medical Sciences Academy Conference (IMSACON) 2005, Jaipur October 23rd

“Protocol considerations in selection of volunteers and subjects” – Indian Council of Medical Research (ICMR) workshop, KEM Hospital, Mumbai September 27th, 2005

“Antimicrobial chemotherapy – precautions and irrational combinations” – 3rd certificate course in hospital infection control at the Tata Memorial Hospital Mumbai, 26th February 2005.

“Management of Infections in renally impaired patients” – Guest Lecture at the Hospital Infection Society National Conference, Hyderabad, January 30th, 2005

“Phase 1 studies” - Guest Lecture at ICMR Workshop in Clinical Pharmacology, KEM Hospital, Department of Clinical Pharmacology, December 9th, 2004

“Role of Clinical Pharmacologist in the Pharmaceutical Industry” – Guest Lecture at ICMR Workshop in Clinical Pharmacology, KEM Hospital, Department of Clinical Pharmacology, November 29th, 2004

“Cardiovascular Disease Management Program” – Presentation at the 2nd Annual International Disease Management Summit, Orlando, Florida, US, October 19-20th 2004

“Management of Hyperlipidemia” Guest Lecture at Department of Clinical Pharmacology KEM Hospital Mumbai, August 26, 2004

“From Evidence to Practice” – Guest Lecture at Annual Function & Regional CME API Varanasi Chapter, 7th August 2004

“Regulatory approval of new drugs in India‟ – Guest Lecture at Department of Clinical Pharmacology KEM Hospital Mumbai, July 14, 2004

“Drug Discovery and Development” – Diploma Course in Clinical Research conducted by Academy for Clinical Excellence at Bombay College of Pharmacy, Kalina, 17th April 2004. “Antimicrobial chemotherapy – precautions and irrational combinations” – 2nd certificate course in hospital infection control at the Tata Memorial Hospital Mumbai, 28th February 2004.

“Achieving an optimal outcome in treatment of infections – the role of pharmacokinetics and pharmacodynamics of antimicrobials” – CME in Clinical Microbiology and Infectious Diseases at Global Hospitals, Hyderabad 9th-12th January, 2004.

“Literature Review” at the ICMR and DDF Nair Hospital sponsored National workshop for Post-graduate teachers on Clinical Research Methodology on 19th-20th December, 2003.

“Cardio-Renal Cascade in Hypertensives” at the 34th Annual Conference of the Indian Society of Nephrology, Visakhapatnam on 6th December, 2003.

“Good Clinical Practice” at KEM Hospital for the PHARMATECH 2002 workshop on 17th April, 2002.

“Hyperhomocysteinemia and Folic acid deficiency in Indians” at the National Symposium on “Neural Tube Defects and Folic Acid Deficiency‟ at AIIMS, New Delhi on 5th March, 2002.

“Antibiotic Use in Laparoscopic Surgery” on 5th August, 2001 in Delhi for the core committee on the first Indian guidelines for Minimal Access Surgery.

“Guidelines on Guidelines” - for the core committee on the first Indian guidelines for Minimal Access Surgery in Delhi on 1st July, 2001 and for the core committee on the first Indian guidelines for Febrile Neutropenia in Mumbai on 14th July, 2001.

“Diabetic Foot Infection Control” - at Bombay Hospital S. P. Jain Auditorium, Clinical Meeting on Diabetic Neuropathy organized by Dr Tambwekar on 12th August, 2001.

“Types and Designs of Clinical Trials” - at a workshop for students of alternative medicine at KEM Hospital on 16th April, 2001.

“Clinical relevance of extended spectrum β-lactamases and their impact on healthcare associated infections” - at a meeting of the Hospital Infection Society of India, Mumbai branch, at Hinduja Hospital on 10th April, 2001.

“Life-threatening infections and their management” - Panel discussion at the Goregaon Medical Association meeting on 3rd December, 2000.

“Bacterial resistance‟ - a symposium at the Nehru Science Center on 8th August, 2000.

Training:

G.C.P. Workshop in Hotel Sea Princess, Mumbai, September 1999. ∙ PRE Certification (from 25.10.99 to 30.11.99).

Interdivisional Workshop and workshop on self-development and team building at Khandala in November 1999.

Worldwide Sulperazon Product Physician meeting at Seville, Spain in January 2000. ∙ Global forum on Surgical Infections, Singapore, October 2000.

Medical Orientation Seminar, PPG, Pfizer Inc, New York in October 2000.

Time management Workshop in Pfizer HO, Mumbai, November 2000.

Interdivisional Workshop and workshop on self-development and team building at Silvassa in November 2000.

G.C.P. Workshop in N. Delhi, February 2001.

Worldwide Sulperazon Product Physician meeting at Istanbul, Turkey in March 2001.

Global Forum on Respiratory Tract Infections, Phuket, Indonesia, August 2001.

MRD Workshop and workshop on self-development and team building at Goa in March 2002.

Worldwide Sulperazon Product Physician meeting at Stresa, Italy in April, 2002. Cardiovascular Planning Week (Norvasc, Lipitor, Caduet, Accupril), Berlin, August 27- 30th, 2002

Train the Trainers on Leader Behaviors and Understanding the 360 degree feedback process and Accelerate Workshop, on 17th-18th and 24th-25th November, 2003 at Hotel ITC Grand Maratha Sheraton, Mumbai.

Project Management Workshop, Conducted by IIM, Bangalore, Hotel Taj Lands End, 20th- 21st February 2004.

CV Planning Week, (Norvasc, Lipitor, Caduet, Inspra, Exubera, Torcetrapib), Budapest March 29-April 2, 2004.

Biometrics Workshop, Conducted by Asia-AfME Biometrics Center, Sydney at Hotel JW Marriott, Mumbai 19th-20th April 2004.

Global Medical Information Preceptorship program at the Pfizer New York office June 14- 18, 2004

International Disease Management Summit, Orlando, Florida, US, October 19-20, 2004 ∙ General Management Development Program conducted by professors of IIM Ahmedabad, Dec 13th to 18th, Hotel Resort, Malad, Mumbai

Daisy – one day training program in Outcomes Research, Shanghai 8th March 2006 ∙ LEADING EDGE II – Train The Trainer program, Kuala Lumpur, February 2008 ∙ Continuous Improvement – Yellow Belt training, Mumbai 2009

Green Belt Six Sigma Training, Kuala Lumpur, April 2010

Prevenar 13 Train the Trainer, Hong Kong, April 2010

Crisis Management Workshop, Regional Asia Training Week, Putrajaya, July 16, 2010

Empathetic communication workshop, Mumbai, January 17-18, 2011

Global Thrombosis Forum, Barcelona, March 19-20, 2011 (10 credit points) ISCR Regulatory Workshop, August 31, 2012, Hotel Mirador, Mumbai

Conferences Attended:

European Society of Cardiology 2011, August, Paris

International Society of Pharmacoeconomics and Outcomes Research (ISPOR), 2nd Asia Pacific Conference, Shanghai March 6th-7th 2006

Confronting the Challenge of Global Clinical Trials, sponsored by Chemtech, Hotel Intercontinental The Grand, October 25th, 2004

Medical Affairs: Business Imperatives. OPPI, 19th March 2004, Hotel Marriott, Mumbai. Pharmacoeconomics, Tata Memorial Hospital & Dept. of Clinical Pharmacology K.E.M. Hospital, July 11, 1999.

Conference on HT, DM & Lipids, Hyderabad, February 25 – 28, 1999.

Golden Jubilee Conference of the Cardiological Society of India, Mumbai, December 10- 14, 1998.

C.M.E. - Ethical Issues in Research - K.E.M. Hospital, April 1998.

Advances in Clinical Pharmacology Conference and Workshop on Basics of Clinical Pharmacology - KEM Hospital, February 1998.

Update Ayurveda - KEM Hospital - February 1998.

PHARMACON - 97 National Seminar - Somaiya Medical College, December 1997. Mid Term Conference of ISCPT, Sion Hospital, September 1997.

XXIXth Annual Conference of Pharmacologists of Maharashtra, Dhule, January 1997.

The XXIXth Annual Conference of the Indian Pharmacological Society, Hyderabad, December 1996.

PHARMATECH - Workshop of P.G. Students in Pharmacology, KEM Hospital, October 1996.

Extra-Curricular Activities:

Won several prizes in Debates, Elocution and Dramatics at Inter-School/ Inter-Collegiate and Inter-Medical-Collegiate (All India) Competitions.

Runner up Team - “RALLIS TROPHY”- 1988. (Inter-Medical Audio-Visual Presentation at Bombay Medical Congress).

Indian Academy of Pediatrics Quiz -1988, Winner Team among students of T.N.M.C. Represented Topiwala National Medical College and Nair Hospital in Cricket and won Best Batsman Awards.

Member of winning team at the interdivisional cricket competition during the Pfizer 50 year celebrations.

Member:

Indian Society for Clinical Research (ISCR)

Indian Pharmacological Society (peer reviewer for the Journal)

Association of Physicians of India

Indian Medical Association

Venous Association of India

Hospital Infection Society of India

Infectious Diseases Society of India

Ex-Executive Council, and Chair of the Investigator Council, Indian Society for Clinical Research

Ex-Chair and Member of the India-EFPIA Regulatory Forum

Section Editor – Journal of ISCR (Perspectives in Clinical Research) General Practitioners Association

Ex-OPPI Medical, Biotechnology, Ethics and Compliance Committee; member Working Group on Innovation and IPR

Drug Information Association

Indian Society of Pharmacoeconomics and Outcomes Research (ISPOR)